Study of methods for state regulation of prices and costs of the health care system for medicines in the United Kingdom

Study of methods for state regulation of prices and costs of the health care system for medicines in the United Kingdom

Objective: analysis of state regulation of prices and costs for the purchase of medicines (drugs) in the United Kingdom (UK), and proposal development to improve the processes of state regulation of manufacturers’ marginal registered prices of medicines included in the list of vital and essential dr...

Full description

Bibliographic Details
Main Authors:	A. A. Leshkevich, D. S. Yurochkin, Z. M. Golant, I. A. Narkevich
Format:	Article
Language:	Russian
Published:	IRBIS LLC 2022-04-01
Series:	Фармакоэкономика
Subjects:	pricing methodology state regulation of drug prices in the united kingdom branded medicines generic medicines health care digitization
Online Access:	https://www.pharmacoeconomics.ru/jour/article/view/656

Similar Items

Review of calculation methods, procedures for registration and re-registration of producer prices of medicines in the countries of the Eurasian Economic Union
by: A. A. Leshkevich, et al.
Published: (2020-08-01)

How large are the differences between originator and generic prices? Analysis of five molecules in 16 European countries
by: Sabine Vogler
Published: (2012-12-01)

Generic Medicine Pricing Policies in Europe: Current Status and Impact
by: Pieter Dylst, et al.
Published: (2010-03-01)

New pricing models for generic medicines to ensure long-term sustainable competition in Europe
by: Clement Francois, et al.
Published: (2023-10-01)

Relationship between pharmaceutical pricing strategies with price, availability, and affordability of cardiovascular disease medicines: surveys in Qatar and Lebanon
by: N. Abdel Rida, et al.
Published: (2019-12-01)

Factors Influencing the Selection of Methods and Determination of Transfer Pricing in Multinational Companies: A Case Study of United Kingdom
by: Zeki Dogan, et al.
Published: (2013-09-01)

Generic Medicine and Generic Prescribing in Nepal: An Implication for Policymakers
by: Shrestha R, et al.
Published: (2022-02-01)

A comparison of generic drug prices in seven European countries: a methodological analysis
by: Olivier J. Wouters, et al.
Published: (2017-03-01)

Price developments of the first level of anatomic-therapeuticchemical classification of regulated medicines
by: Štefan Bojnec, et al.
Published: (2013-10-01)

Has the increase in the availability of generic drugs lowered the price of cardiovascular drugs in South Africa?
by: Varsha Bangalee, et al.
Published: (2016-10-01)

Has the increase in the availability of generic drugs lowered the price of cardiovascular drugs in South Africa?
by: Varsha Bangalee, et al.
Published: (2016-12-01)

Availability of anticancer medicines in public and private sectors, and their affordability by low, middle and high-income class patients in Pakistan
by: Muhammad Rehan Sarwar, et al.
Published: (2018-01-01)

The Impact of Tiered-Pricing Framework on Generic Entry in Canada
by: Wei Zhang, et al.
Published: (2022-06-01)

The impact of centralized electronic bidding system on procurement prices for generic medicines: A case study from Thailand
by: Amarawan Pentrakan, et al.
Published: (2022-12-01)

Generic cardiology drug prices: the potential benefits of the Marc Cuban cost plus drug company model
by: Aparna Narendrula, et al.
Published: (2023-08-01)

Biosimilar medicines: creating sustainable competition in an era of a new patent cliff in biological medicines
by: Maarten Van Baelen
Published: (2015-12-01)

Pharmacy Compounding Regulation in the German Pharmaceutical Market. Part 1. Basic Regulatory Provisions (Review)
by: S. E. Erdni-Garyaev, et al.
Published: (2024-02-01)

Generic substitution for prescribed brand medicines in Ethiopia: knowledge, attitude and practice among pharmacy professionals in community drug retail outlets
by: Sintayehu Alemu, et al.
Published: (2022-07-01)

Cardiovascular medicine prices as an indicator of access to medicines and their rational use
by: C M. Razzakova, et al.
Published: (2019-05-01)

New prices for generic equivalent drugs
by: Ombretta Bandi
Published: (2011-11-01)

Narratives of Herbal Medicine Utilisation in the United Kingdom: Scoping Literature Review
by: Celine Longden-Naufal, et al.
Published: (2022-08-01)

Implementation of Medicines Pricing Policies in Ghana: The Interplay of Policy Content, Actors’ Participation, and Context
by: Augustina Koduah, et al.
Published: (2023-12-01)

Monitoring Cardiovascular Medicine Prices as a Tool for Analyzing the Effectiveness of Government Intervetions to Ensure Access to Medicines at the Regional Level
by: C. M. Razzakova, et al.
Published: (2020-12-01)

Aggregate Online Brand Name Pharmacy Price Dynamics for the United States and Mexico
by: Thomas M. Fullerton, et al.
Published: (2022-05-01)

Impact of the Low-Price Medicine Policy on Medicine Supply in China: An Interrupted Time-Series Analysis
by: Mingyue Zhao, et al.
Published: (2021-02-01)

Knowledge and perceptions of medical students about generic medicines in a medical college in North India
by: Anita Kumari, et al.
Published: (2023-01-01)

Multi stakeholders of health and industries perspectives on medicine price transparency initiative in private health care settings in Malaysia
by: Nur Sufiza Ahmad, et al.
Published: (2020-07-01)

United States – United Kingdom military cooperation under Donald Trump’s administration (2017 – 2021)
by: Nazarii Lutsenko
Published: (2021-06-01)

Analysis of the level and dynamics of prices in the pharmaceutical market in Russia and its use to assess the effectiveness of state regulation of prices for medicines
by: A. S. Orlov
Published: (2015-06-01)

PERINTAH Kawalan Harga (Pelabelan oleh Pekilang, Pengimport, Pengeluar atau Penjualborong) 1980.

Akta KAWALAN Harga (Pindaan) 1974.

An exploration of factors influencing the selection of generic and innovator medicines in Saudi Arabia using an observational cross-sectional study
by: Othman AlOmeir, et al.
Published: (2024-04-01)

Dynamics of price competition in Italian pharmaceutical off-patent market
by: Serena Perna, et al.
Published: (2022-11-01)

Comparative price analysis of biological medicines: disparities generated by different pricing policies
by: Marcela Amaral Pontes, et al.
Published: (2024-01-01)

IMPROVEMENT OF PRICE REGULATION FOR INNOVATIVE MEDICINES COVERED BY THE NATIONAL BUDGET
by: V. A. Lemeshko, et al.
Published: (2018-02-01)

Perception toward low-cost generic medicines and their usage among dental patients visiting community outreach programs in the peripheral areas of Bangalore South: An exploratory cross-sectional survey
by: Nigy Johnson, et al.
Published: (2020-01-01)

Use of Generics—A Critical Cost Containment Measure for All Healthcare Professionals in Europe?
by: F. Cankat Tulunay, et al.
Published: (2010-08-01)

Price distortions and growth in developing countries /
by: 313174 Agarwala, Ramagopal
Published: (1983)

Why do people choose to purchase generic antibiotics?
by: Thianti Sylviningrum, et al.
Published: (2012-07-01)

The Brazilian private pharmaceutical market after the first ten years of the generics law
by: Andréa Dâmaso Bertoldi, et al.
Published: (2019-12-01)